Galderma Group AGXSWX:GALD -0.14%15 Days Inventory is 108.67 as of Dec. 2025, which is 0% below its 10-year median of 109.15. GuruFocus rates XSWX:GALD with a GF Score™ of 15/100. The stock has 4 warning signs investors should review. Among 916 Drug Manufacturers companies, Galderma Group AG ranks better than 74.56% on this metric.
The historical rank and industry rank for Galderma Group AG's Days Inventory or its related term are showing as below:
XSWX:GALD'
s Days Inventory Range Over the Past 10 Years
Min: 109.13 Med: 109.15 Max: 124.43
Current: 109.9
During the past 5 years, Galderma Group AG's highest Days Inventory was 124.43. The lowest was 109.13. And the median was 109.15.
XSWX:GALD's Days Inventory is ranked better than 74.56% of 916
companies
in the Drug Manufacturers industry
Industry Median: 164.43
vs XSWX:GALD: 109.90
Galderma Group AG's Days Inventory
increased
from Dec. 2024 (108.50) to Dec. 2025 (108.67).
It might indicate that Galderma Group AG's sales slowed down.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Galderma Group AG's Inventory Turnover for the
six
months ended in Dec. 2025 was 1.68.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Galderma Group AG's Inventory-to-Revenue for the
six
months ended in Dec. 2025 was 0.19.
Galderma Group AG (XSWX:GALD) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Galderma Group AG's Inventory Turnover for the
six
months ended in Dec. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Galderma Group AG's Inventory to Revenue for the
six
months ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Galderma Group AG Days Inventory Related Terms
Galderma Group AG Days Inventory Historical Data
* Premium members only.
The historical data trend for Galderma Group AG's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XSWX:GALD vs ZTS, UTHR, VTRS: Days Inventory Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Galderma Group AG's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Galderma Group AG Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Galderma Group AG's Days Inventory distribution charts can be found below:
* The bar in red indicates where Galderma Group AG's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Galderma Group AG (XSWX:GALD) has a Days Inventory of 108.67 as of Dec. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Galderma Group AG and its competitors. This is near median its historical median of 109.15. Over the past decade, Galderma Group AG's Days Inventory has ranged from 109.13 to 124.43. According to the industry distribution chart, Galderma Group AG ranks #233 out of 916 companies in the Drug Manufacturers industry, placing it in the top 25.4%.
Is Galderma Group AG's Days Inventory too high?
Galderma Group AG's current Days Inventory of 108.67 is near median its 10-year median of 109.15. Over the past 10 years, this metric has ranged from a low of 109.13 to a high of 124.43. The Drug Manufacturers industry median Days Inventory is 164.43. Galderma Group AG's value of 108.67 is 33.9% below this industry median. Based on the distribution chart, Galderma Group AG ranks #233 out of 916 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Galderma Group AG has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does Galderma Group AG's Days Inventory compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Galderma Group AG ranks #233 out of 916 companies for Days Inventory. This puts Galderma Group AG in the upper half of its industry. The industry median Days Inventory is 164.43. Galderma Group AG's value of 108.67 is 33.9% below this benchmark. Historically, Galderma Group AG's own Days Inventory has ranged from 109.13 to 124.43 over the past decade. While the company's 10-year median is 109.15 vs. the industry median of 164.43, Galderma Group AG has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.43, based on 916 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Galderma Group AG's current Days Inventory of 108.67 is 33.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Galderma Group AG and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.43 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Galderma Group AG's current Days Inventory is 108.67, which is near median its own 10-year median of 109.15. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Galderma Group AG stock overvalued right now?
Galderma Group AG (XSWX:GALD) has a current Days Inventory of 108.67. The current Days Inventory is 108.67, which is near median its 10-year median of 109.15 and 33.9% below the Drug Manufacturers industry median of 164.43. Galderma Group AG's overall GF Score™ is 15/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Galderma Group AG (XSWX:GALD), the current Days Inventory is 108.67 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Galderma was formed in 1981 as a joint venture between Nestle and L'Oreal. It subsequently became a subsidiary of Nestle, called Nestle Skin Health, before being carved out and launched as a stand-alone company in 2019, acquired by a consortium led by Sweden-based EQT fund. The company went public in March 2024 and is listed on the SIX Swiss exchange. Galderma's science-based portfolio spans multiple dermatology categories, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. It derives around 40% of net sales from the US and employs more than 7,500 people.
15GF Score
Get the complete analysis for XSWX:GALD
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:GALD has been successfully added to your 